by Micah Harman | Jun 14, 2024 | News & Media
By Joe Petroziello — Pharmaceutical Executive June 13, 2024 Novel approaches against chronic inflammation could potentially prevent certain inflammatory diseases and neurological conditions. During BIO International Convention 2024, CEO Dave Bearss, PhD, of... by Micah Harman | Jun 14, 2024 | News & Media
Chronic inflammation goes hand-in-hand with many diseases, complicating symptoms and affecting routes of treatment. What is the molecular basis of inflammation, and can it be targeted by new drugs? Scientists have studied the molecular basis of the inflammatory... by Micah Harman | Jun 12, 2024 | News & Media
Venture Capital Podcast has released their Founder 100 honoree list for Utah. It is a crowd-nominated, peer-voted list of the state’s top founders in terms of their attractiveness to investors. The honorees and a large group of investors will meet this evening... by Micah Harman | Jun 4, 2024 | News & Media
By Brittny Goodsell — Utah Business Magazine David Bearss, CEO of Halia Therapeutics, says his company uses Carta to manage multiple things. “Biotech companies are always in need of large capital raises to support the expenses from clinical development of new... 
by Micah Harman | May 24, 2024 | News & Media
BioCentury Guided by human variation in the GTPase RAB10, Utah-based company seeks to disrupt inflammasome assemblyBY RICHARD GUY, BIOPHARMA ANALYSTMay 23, 2024 Halia has a new take on drugging the NLRP3 inflammasome that centers on exploiting RAB10 biology to control... by Micah Harman | May 1, 2024 | News & Media
By Heather Bergerson — Utah Business Magazine Utah-based companies Halia Therapeutics and Canary Speech are collaborating to revolutionize how Alzheimer’s disease can be monitored and treated. https://bit.ly/3z2AhkH by Micah Harman | Apr 1, 2024 | News & Media
Beyond Employee Engagement: Unpacking Performance in Life Sciences Leadership – Executive Roundtable April 1, 2024 In this insightful episode of Conversations Life Science Leaders Aren’t Having, Jeff Harmon hosts an invaluable Life Science Executive... by Micah Harman | Mar 21, 2024 | News & Media
March 20, 2024/28:57/E24012 In this episode of BioTech Nation, Dr. David Bearss, President, and CEO of Halia Therapeutics, discusses inflammation and its reduction over a lifetime and in response to various incidents. He unveils the inflammasome, a recently discovered... by Halia Therapeutics | Feb 16, 2024 | News & Media
The study will enroll up to 80 adults who are undergoing the surgical removal of two or more molar teeth for inflammatory and pain management. February 16, 2024 US-based biopharmaceutical company Halia Therapeutics has begun a Phase II clinical trial to... 
by Halia Therapeutics | Feb 9, 2024 | News & Media
Halia Therapeutics Inc. and Canary Speech Inc. have established a collaboration in Alzheimer’s disease. This collaboration leverages Canary Speech’s artificial intelligence (AI) vocal biomarker platform, which utilizes advanced AI algorithms to analyze subtle changes... by Halia Therapeutics | Feb 1, 2024 | News & Media
Lee LandenbergerJanuary 31, 2024 Halia Therapeutics Inc. has, its CEO confidently asserts, taken an atypical road to building its infrastructure and financing. The Lehi, Utah-based company just completed a $30 million series C financing to further develop its lead... 
by Halia Therapeutics | Jan 17, 2024 | News & Media
Biotech Acquisitions Heat Up, Giving Venture Capitalists Hope for 2024 ‘Investors and entrepreneurs also are wrestling with questions such as the impact of the 2022 Inflation Reduction Act, which enabled Medicare to negotiate prices of certain medications, said... 
by Halia Therapeutics | Jan 11, 2024 | News & Media
January 11th, 2024 Author: Danny Sullivan Dr. David Bearss was featured in Longevity.Technology discussing Halia Therapeutics moving into multiple Phase 2 trials for chronic inflammation and whether the company may have created a ‘longevity drug.’ Fresh from... 
by Halia Therapeutics | Jan 4, 2024 | News & Media
Alternative Funding Strategies to Discuss at JPM The last year has demonstrated that a sound financing strategy and compelling company narrative are essential to securing funding – it’s become more important than ever that investors are excited before taking the... 
by Halia Therapeutics | Dec 11, 2023 | News & Media
One aspect of 2023 our group of executives completely agreed on: the past year was tough financially. And they all foresee a more vibrant year ahead for the market. Giving all of them hope were technological breakthroughs such as artificial intelligence, game changing... by Halia Therapeutics | Dec 8, 2023 | Press Releases, News & Media
The Phase II trial of HT-6184 will enroll around 50 patients with MDS who are or are on the borderline of being transfusion-dependent. Halia Therapeutics is looking to start a Phase II trial of its pipeline candidate HT-6184 in myelodysplastic syndrome (MDS) early... by Halia Therapeutics | Dec 8, 2023 | News & Media
Starting a company is interesting. I’m a scientist by training and have often considered myself the world’s most reluctant entrepreneur. Halia Therapeutics is the sixth company I’ve started, but most of the time, I still think of myself as the guy who used... 
by Halia Therapeutics | Nov 29, 2023 | News & Media, Press Releases
LEHI, Utah, Nov. 29, 2023 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced positive results following the... 
by Halia Therapeutics | Sep 19, 2023 | News & Media
“David Bearss’ passion for drug discovery has guided his noteworthy career as a dynamic leader who integrates scientific and business interests to deliver new medicines to patients. That passion is still evident today as he gives back to the industry he loves,... 
by Halia Therapeutics | Sep 18, 2023 | News & Media
“Halia Therapeutics believes it is on the forefront of research to target chronic inflammation to treat neurodegeneration and inflammatory diseases. Chronic inflammation causes more health issues than the average person may realize. It causes arthritis, anemia,...